Comphya
Phase 1Comphya is developing CaverSTIM™, a novel implantable neuromodulation system designed to support erectile nerve function after urologic surgery, including prostate cancer surgery.
Founded
2019
Focus
Digital HealthAI / Machine Learning
About
Comphya is developing CaverSTIM™, a novel implantable neuromodulation system designed to support erectile nerve function after urologic surgery, including prostate cancer surgery.
Company Info
TypePrivate
Founded2019
LocationLausanne, Switzerland
StagePhase 1
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile